Výsledky vyhledávání

Akademický článek

DNA copy number motifs are strong and independent predictors of survival in breast cancer.

Autor: Pladsen AV; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway., Nilsen G; Centre for Bioinformatics, Department of Informatics, University of Oslo, Gaustadalléen 23 B N-0373, Oslo, Norway., Rueda OM; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Aure MR; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway., Borgan Ø; Department of Mathematics, University of Oslo, Moltke Moes vei 35 N-0851, Oslo, Norway., Liestøl K; Centre for Bioinformatics, Department of Informatics, University of Oslo, Gaustadalléen 23 B N-0373, Oslo, Norway., Vitelli V; Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Domus Medica, Sognsvannsveien 9 N-0372, Oslo, Norway., Frigessi A; Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Domus Medica, Sognsvannsveien 9 N-0372, Oslo, Norway., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway., Mathelier A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway.; Centre for Molecular Medicine Norway, University of Oslo, Forskningsparken, Gaustadalléen 21 N-0349, Oslo, Norway., Engebråten O; Institute for Clinical Medicine, University of Oslo, Kirkeveien 166 N-0450, Oslo, Norway.; Department of Oncology, Oslo University Hospital, POB 4953 Nydalen, N-0424, Oslo, Norway., Kristensen V; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway., Wedge DC; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7FZ, UK.; NIHR Biomedical Research Centre, Warneford Ln, Headington, Oxford, OX3 7JX, UK., Van Loo P; The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Caldas C; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway.; Institute for Clinical Medicine, University of Oslo, Kirkeveien 166 N-0450, Oslo, Norway., Russnes HG; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway.; Department of Pathology, Oslo University Hospital, POB 4953 Nydalen N-0424, Oslo, Norway., Lingjærde OC; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Ullernchausseen 70 N-0310, Oslo, Norway. ole@ifi.uio.no.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Gaustadalléen 23 B N-0373, Oslo, Norway. ole@ifi.uio.no.; KG Jebsen Centre for B-cell malignancies, Institute for Clinical Medicine, University of Oslo, Ullernchausseen 70 N-0372, Oslo, Norway. ole@ifi.uio.no.

Publikováno v: Communications biology [Commun Biol] 2020 Apr 02; Vol. 3 (1), pp. 153. Date of Electronic Publication: 2020 Apr 02.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Historical Biobanks in Breast Cancer Metabolomics- Challenges and Opportunities.

Autor: Madssen TS; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Cao MD; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Pladsen AV; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway., Ottestad L; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway.; Department of Oncology, Østfold Hospital Trust, 1714 Kalnes, Norway., Sahlberg KK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, 0310 Oslo, Norway.; Department of Research and Innovation, Vestre Viken Hospital Trust, 3004 Drammen, Norway., Bathen TF; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway., Giskeødegård GF; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Publikováno v: Metabolites [Metabolites] 2019 Nov 13; Vol. 9 (11). Date of Electronic Publication: 2019 Nov 13.

Zobrazit plný text záznamu

Akademický článek

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.

Autor: Fleischer T; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Klajic J; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway.; Department of Clinical Molecular Biology and Laboratory Science (EpiGen), Akershus University hospital, Division of Medicine, Lørenskog, Norway., Aure MR; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Louhimo R; Systems Biology Laboratory, Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, Finland., Pladsen AV; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Ottestad L; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Touleimat N; Laboratory for Epigenetics and Environment, Centre National de Génotypage, CEA - Institut de Génomique, France., Laakso M; Systems Biology Laboratory, Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, Finland., Halvorsen AR; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Grenaker Alnæs GI; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Riis ML; Department of Clinical Molecular Biology and Laboratory Science (EpiGen), Akershus University Hospital, Division of Medicine, Lørenskog, Norway.; Department of Surgery, Akershus University Hospital, Lørenskog, Norway.; Deptartment of Breast and Endocrine Surgery, Oslo University Hospital, Ullevål, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway.; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Hautaniemi S; Systems Biology Laboratory, Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, Finland., Lønning PE; Section of Oncology, Institute of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Naume B; Cancer Clinic, Oslo University Hospital Radiumhospitalet, Oslo, Norway., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway., Tost J; Laboratory for Epigenetics and Environment, Centre National de Génotypage, CEA - Institut de Génomique, France., Kristensen VN; Department of Cancer Genetics, Institute for Cancer Research, OUS Radiumhospitalet, Oslo, Norway.; Department of Clinical Molecular Biology and Laboratory Science (EpiGen), Akershus University hospital, Division of Medicine, Lørenskog, Norway.

Publikováno v: Oncotarget [Oncotarget] 2017 Jan 03; Vol. 8 (1), pp. 1074-1082.

Zobrazit plný text záznamu